Background. Recent studies regarding immunoglobulin A nephropathy (IgAN) suggest no relationship between pregnancy and disease progression, although complicated pregnancies and impaired renal function are closely related. Methods. This study used a propensity-score-matched cohort analysis. Among biopsy-confirmed IgAN women in three hospitals in Korea, those who experienced pregnancy after their diagnosis were included in the study group. Renal outcome was the composite of serum creatinine doubling, estimated glomerular filtration rate (eGFR) halving and events of end-stage renal disease. Pregnancies with preterm birth, low birth weight and pre-eclampsia were defined as complicated. Results. Overall, 59 IgAN women who became pregnant after their diagnosis, and the same number of IgAN women who did not experience pregnancy were included in the control group. Although pregnancy itself did not worsen renal outcomes [adjusted hazard ratio (HR): 1.51; 95% confidence interval (CI) 0.57-4.01; P ¼ 0.41], mothers with complicated pregnancies experienced worse renal prognosis, even after adjustment for baseline and pregestational characteristics (adjusted HR: 5.07; 95% CI 1.81-14.22; P ¼ 0.002). Moreover, this relationship was only significant in mothers with decreased renal function (eGFR <60 mL/min/1.73 m
I N T R O D U C T I O N
Immunoglobulin A nephropathy (IgAN) is the most common type of primary glomerulonephritis, and it is an important cause of kidney function deterioration, leading to end-stage renal disease (ESRD) [1, 2] . As most patients with IgAN are diagnosed during their 20s and 30s [2, 3] , the common childbearing period in women, planning childbirth has been a crucial issue for women with IgAN.
Previously, pregnancy in patients with chronic kidney disease (CKD) was thought to be associated with a failure of the kidneys to adapt to the physiological changes of pregnancy, consequently contributing to adverse renal outcomes [4, 5] . However, some studies have shown that pregnancy affected neither renal prognosis nor survival in patients with IgAN [6] [7] [8] [9] [10] . There are several limitations associated with these conflicting results, and these should be clarified and overcome in future studies to determine the complex effect of pregnancy on renal prognosis in women with IgAN Recent studies have shown that pregnancy in patients with CKD may lead to worse maternal-foetal outcomes even from the early stages [10] [11] [12] [13] . Although a non-negligible number of complicated pregnancies were included in previous studies regarding IgAN, the impact of this gestational complication on renal prognosis was not emphasized [8, 9] . Next, such studies analysed data collected during a short follow-up period and for a small number of women with IgAN, most of whom had preserved renal function [6] [7] [8] [9] .
In the present study, we aimed to assess the relationship between pregnancy and renal prognosis in women with IgAN. We used propensity-score matching and stratified pregnancies into two subcategories (complicated and uncomplicated) to investigate further whether obstetric complications are associated with renal prognosis.
M A T E R I A L S A N D M E T H O D S

Ethics statement
This study was approved by the institutional review boards of the Seoul National University Hospital (SNUH, IRB No. H-1504-093-666), the Seoul National University Bundang Hospital (SNUBH, IRB No. B-1506/304-302) and the Asan Medical Center (AMC, IRB No. 2016-0959). This study was conducted in accordance with the principles of the Declaration of Helsinki. As we performed a retrospective study, informed consent for electronic health record (EHR) review was waived. In addition, phone interviews were performed after acquiring direct verbal consent from the subjects.
Study population
Data from all women with biopsy-proven IgAN from three hospitals were reviewed. IgAN was diagnosed by immunofluorescence microscopy showing mesangial IgA deposition as the predominant or co-dominant immunoglobulin. Patients aged <15 years at diagnosis, with evidence of a secondary cause of IgAN, with a follow-up duration of <6 months, with missing baseline information and those who were receiving renal replacement therapy at the time of diagnosis were excluded from the study. IgAN mothers who experienced pregnancy after their diagnoses were included in the study group, and the control group was formed by propensity-score-based matching.
Data collection
An EHR review was done to collect data from patients with IgAN. Demographic and clinical parameters were obtained at the time of kidney biopsy, including age, body mass index (BMI), diabetes mellitus, hypertension and medication history. Serum and urinary laboratory results were extensively reviewed from the time of renal biopsy to the time of the last follow-up. As methods for serum creatinine measurement changed over time, all serum creatinine levels were recalibrated for an isotope-dilution mass spectrometry assay (Roche Diagnostics). The estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease equation [14] .
Proteinuria was assessed using either a random urine proteinto-creatinine ratio or a 24-h urinary protein measurement.
Pathological parameters were reviewed as previously described [1, 15] . All native renal biopsies were processed using standard techniques for light microscopy, immunofluorescence and electron microscopy. Histopathological changes were evaluated by two pathologists, who reviewed the renal biopsy slides.
Additionally, we collected pre-gestational clinical characteristics, including age, BMI, parity, degree of proteinuria and presence of hypertension. Pre-gestational renal function was evaluated by the last measured eGFR before the estimated conception date and within 3 years from the delivery date. When describing peri-gestational alterations in renal function, maximal eGFR values at baseline, at each trimester of pregnancy and after delivery were plotted. In addition, preterm birth was defined as a delivery with a gestational age <37 weeks [16, 17] ; low birth weight was defined as a birth weight <2.5 kg [17, 18] ; and pre-eclampsia was diagnosed by an obstetrician at the time of delivery by combining findings of hypertension, proteinuria and end-organ damage. A complicated pregnancy was defined as one in which the composition of the three above-mentioned adverse pregnancy outcomes occurred for a single pregnancy: preterm birth, low birth weight and pre-eclampsia. In addition, very low birth weight was defined as a birth weight <1.5 kg, and early preterm birth was defined as a delivery with gestational age <34 weeks. Small for gestational age was defined as a weight at delivery below the 10th percentile for the gestational age.
Moreover, we performed phone interviews to obtain information regarding deliveries that occurred outside the hospitals. A total of five experienced clinical research nurses called the women with IgAN. The calls were attempted at least three times for each subject to reduce the rate of non-responders, and the survey proceeded only after obtaining informed consent from the subjects.
Outcome assessment
The following renal outcomes and their development data were evaluated: patients whose serum creatinine levels were doubled in relation to baseline levels; patients whose eGFR was halved in relation to baseline values; and patients who started maintenance renal replacement therapy. To include the outcomes associated with the progression of ESRD, we reviewed the EHR database and the national renal replacement treatment database maintained by the Korean Society of Nephrology [19] .
Statistical analysis
Categorical variables were shown as percentages and frequencies and were analysed using the chi-squared test. Continuous variables were presented as the mean 6 standard deviation, or as median and quartile values, and were analysed using the Student's t-test or the median test according to the normality of the data. Normality was assessed using the Shapiro-Wilk normality test. Propensity-score matching was performed with the 'MatchIt' package in R, using nearest-neighbour matching without replacement, and a calliper value of 0.2.
To perform the survival analyses, we first generated KaplanMeier survival curves with the log-rank test. Next, we used a Cox proportional hazards regression analysis with the 'survival'
package in R to evaluate the effects of pregnancy on renal outcomes. We treated pregnancy as a time-dependent covariate, and first events of pregnancy or complicated pregnancy were used to define the variable. In addition, to compare renal prognosis according to the presence of complicated pregnancies, we divided our matched cohort into three subgroups, as follows: women with IgAN who had at least one complicated pregnancy on record, who had only uncomplicated pregnancies on record and who had no pregnancy after biopsy-proven diagnosis. Multivariate analyses were performed with adjustment for characteristics known to be related to the progression of IgAN: age, BMI, history of hypertension, baseline eGFR and degree of proteinuria. As we used time-varying covariates in the study, in addition to the baseline characteristics, pre-gestational variables were also included in the adjustment when analysing the postpregnancy renal survival [20] . In multivariate analyses, there were no missing values in the baseline information, and imputation by the last-observation-carried-forward method was used for missing information in the pre-gestational characteristics. Lastly, we tested the effect of pregnancy in subgroups defined by the presence of high-risk characteristics for disease progression: decreased eGFR (<60 mL/min/1.73 m 2 ), baseline hypertension and overt proteinuria (!1 g/day or 1 g/g).
As there were mothers with multiple gestational events after their kidney biopsies, we additionally described the characteristics and outcomes of all pregnancy cases. The Kruskal-Wallis oneway analysis of variance and the chi-squared test for linear-bylinear associations were performed to compare pre-gestational characteristics and pregnancy outcomes according to the pregestational eGFR. A linear mixed model with fixed effects was generated using the restricted estimated maximal likelihood method to evaluate differences in eGFR across time phases, comparing complicated and uncomplicated pregnancies. Statistical analyses were performed using SPSS version 22 (IBM software, Armonk, NY, USA) or using R package version 3.2.5 (R Development Core Team, Vienna, Austria). For all analyses, a two-sided P-value with a statistically significant level of 0.05 was used. Figure 1 shows a flow diagram describing the selection of our study population. Among those who were not receiving renal replacement therapy at baseline, our study originally included a total of 802 women whose data were collected between 1979 and 2014 in the SNUH; 181 women whose data were collected between 2003 and 2015 in the SNUBH; and 513 women whose data were collected between 1998 and 2014 in the AMC who were diagnosed with IgAN with pathologic confirmation by percutaneous kidney biopsy at an age >15 years. After exclusion, 1112 women with IgAN were screened for events of pregnancy. Results of EHR review and phone interviews showed that 59 women with IgAN had confirmed pregnancy events after their IgAN diagnoses. Next, the control group was formed by propensity-score matching and ultimately included 59 IgAN women without post-biopsy gestation.
R E S U L T S
Study population
Comparisons of baseline characteristics
Before applying propensity-score matching (Supplementary  Table S1 ), women who experienced pregnancy after IgAN diagnosis were younger than control group (P < 0.001). Further, they had lower BMIs (P ¼ 0.03) and were diagnosed their IgAN at an earlier age (P ¼ 0.002). Pathologic characteristics were not different between the two groups. After 1:1 propensity-score matching, these differences in baseline characteristics between the two groups were lost (Table 1) .
Relationship between pregnancy and renal progression
In the matched cohort, a total of 25 women with IgAN had adverse renal outcomes identified over a median follow-up duration of 7.2 (3.6-10.5) years. Overall renal outcomes were not significantly different between IgAN women with pregnancies and those without (P ¼ 0.60, Figure 2 ). Also, a timedependent Cox proportional hazards analysis with adjustment for baseline and pre-gestational characteristics showed that pregnancy events were not significantly associated with renal prognosis of the patients [adjusted hazard ratio (HR): 1.51; 95% confidence interval (CI) 0.57-4.01; P ¼ 0.41].
Complicated pregnancy and renal prognosis
Next, we tested whether a complicated pregnancy was related to renal outcomes in IgAN. IgAN women with gestational complications had more frequent hypertension histories before becoming pregnant than those without gestational complications. The other baseline and pre-gestational clinical characteristics did not significantly differ between the two groups ( Table 2 ).
In the Kaplan-Meier survival analysis (Figure 3 ), there was a significant difference in renal outcomes among the three subgroups (P < 0.001). For women without pregnancy experience, the renal survival rate was 80.3% at 10 years and 70.4% at 20 years. However, for mothers with complicated pregnancies, the renal survival rate was 55.3% at 10 years and 46.1% at 20 years. Interestingly, IgAN women who experienced pregnancy but no gestational complications had an excellent renal prognosis, even compared with those without post-biopsy pregnancy experience (P ¼ 0.01). Only one woman who delivered without obstetric complications, at 1.4 years after IgAN diagnosis, had doubled serum creatinine and halved eGFR at a follow-up 3.7 years after the IgAN diagnosis. Moreover, IgAN women with complicated pregnancies had worse renal outcomes than those who did not experience any pregnancy (P ¼ 0.04).
In the multivariate analyses, using the first complicated gestation as a time-dependent variable, complicated pregnancy remained a major risk factor for a worse renal outcome (adjusted HR: 5.07; 95% CI 1.81-14.22; P ¼ 0.002), even after adjustment for multiple characteristics (Table 3) . Interestingly, the association between complicated pregnancy and renal progression was different according to the presence of clinical risk factors. The association between complicated pregnancy and disease progression remained significant in those with a decreased eGFR (<60 mL/min/1.73 m 2 ; adjusted HR: 18.70; 95% CI 1.63-214.40; P ¼ 0.02), pre-existing hypertension (adjusted HR: 4.17; 95% CI 1.13-15.33; P ¼ 0.03) and overt proteinuria of at least 1 g/day (adjusted HR: 4.21; 95% CI 1.24-14.27; P ¼ 0.02). In contrast, for those without underlying risk factors, gestational complications were not evidently related to composite renal outcome.
Pregnancy outcomes of women with IgAN
Next, we separately analysed the characteristics of each pregnancy (not the mothers) to assess the relationship between gestational complications and renal function further. Among the study group, 13 mothers had multiple gestation events, and a total of 75 pregnancies were identified, with 64 pregnancy events having information available regarding pre-gestational renal function. The characteristics of those 64 gestations and their pregnancy outcomes are shown in Table 4 . Pregnancy events with relatively preserved pre-gestational eGFR (!90 mL/ min/1.73 m 2 ) were frequently associated with adverse pregnancy outcomes (n ¼ 9, 29%), and those with lower pregestational eGFRs showed even worse prognoses. The relationship remained valid for each pregnancy outcome, although statistical significance was not shown regarding the risks for preeclampsia (P ¼ 0.23).
Peri-gestational renal function according to gestational complications
We plotted the eGFR changes during the peri-gestational period of all pregnancy events in Figure 4 . There were no significant differences regarding the eGFR at baseline (P ¼ 0.21) or during the pre-gestational period (P ¼ 0.09) between pregnancy events with or without obstetrical complications. However, the trend toward gestational eGFR alteration was different between the two groups. There was a significant increase in eGFR from baseline until the third trimester in pregnancies without adverse pregnancy outcomes (P < 0.001), as is common in normal pregnancies. However, this eGFR increase was not observed in the complicated pregnancies (P ¼ 0.57). Taken together, throughout the gestational period, mothers failed to show prominent hyperfiltration during the complicated pregnancies as much as during gestation without adverse pregnancy outcomes (P ¼ 0.01).
D I S C U S S I O N
In the present study, we demonstrated that pregnancy itself did not deteriorate renal function in women with IgAN, as reported in previous studies. Notably, we found that women with IgAN experienced many adverse obstetric complications during pregnancy. These complications manifested chiefly as a loss of eGFR elevation during pregnancies, implicating failure of renal adaptation to occur in response to pregnancy-related haemodynamic changes. Furthermore, these obstetric complications were associated with a worse renal prognosis in mothers with IgAN, especially in those with underlying risk factors, including established renal dysfunction, hypertension and overt proteinuria. Interestingly, however, women with IgAN with uncomplicated pregnancies showed even better renal prognosis than did those without pregnancy events after their diagnosis. Ours is the first study to suggest that the effect of pregnancy on renal outcomes in women with IgAN may differ according to the presence of an obstetric complication. There was evidence that women who experienced gestational complications had adverse renal and other cardio-/cerebrovascular disease outcomes [4, 5, 21, 22] . Additionally, one of the studies showed that pregnancies, regardless of the presence of pre-eclampsia, resulting in low birth weight and preterm birth were strongly related to ESRD progression [23] . However, regarding IgAN, previous studies reported that pregnancy had no significant effect on renal progression by studying mothers with relatively preserved renal function for a short-term followup period and not considering the effects of gestational Characteristics at the pre-gestational period (within 3 years from delivery date) before first complicated or uncomplicated pregnancy were described according to the group. complications [6] [7] [8] [9] 13 ]. In the current study, we provided a differentiated data set that is more compatible with those for the previous large cohort studies, demonstrating the adverse longterm outcomes of gestational complications. Several mechanisms could be suggested for the worse renal prognosis observed in those with gestational complications. First, and fairly reasonable, pregnancy complications and renal progression share common risk factors [9, 12, 24] . As a large proportion of mothers with adverse pregnancy outcomes had baseline or pre-gestational hypertension or overt proteinuria, high-risk mothers were more likely to experience complicated pregnancies and subsequent disease progression. Secondly, as the relationship remained significant even after adjustment for multiple risk factors, women with obstetrical complications might have a decreased renal 'reservoir' that is not apparent in clinical parameters [25] . In the current study, we observed that the increase in eGFR during gestation, also known as physiological renal hyperfiltration during pregnancy [26] , failed to occur in women with IgAN with obstetric complications. Additionally, another recent study reported that mothers with pre-eclampsia who progressed to ESRD were diagnosed with underlying kidney disease later in life [27] . Taken together, the impaired adaptation to the haemodynamic challenge during gestation might reflect subclinical renal dysfunction in those who failed to maintain safe pregnancy [25] . Lastly, complications during pregnancy might have directly damaged the kidney. As the acute postpartum deterioration of renal dysfunction in mothers with advanced CKD stages has been previously reported [4] , the critical events accompanying acute kidney injuries could explain the association, although not all of them, in certain patients.
Interestingly, we found that women with IgAN without obstetric complications showed excellent renal outcomes, even compared with the outcomes of women who did not become pregnant subsequent to the IgAN diagnosis. Considering that previous studies have shown that the rate of pregnancy complications is higher in women with CKD, even if the disease is in early stages [11, 12] , the lack of pregnancy complication may, in itself, indicate that the mother has a relatively stable disease status.
There were several limitations regarding our study. First, our study did not include a large number of women who became pregnant subsequent to a biopsy-confirmed IgAN diagnosis. This was mainly due to excluding patients for whom the followup was short, or for whom data were incomplete, which was necessary to ensure a robust comparison with propensity-scorebased matching and to assess long-term renal prognosis. Secondly, while we reviewed all EHRs of the patients in our cohort, there was a non-negligible number, 504 (45.6%) patients in the total cohort, of patients who were not covered by the phone poll due to refusal or contact failure. However, most of them were older women and, among 619 patients who were aged <40 years, the number of missing young women was 163 FIGURE 4: Change in eGFR during the peri-gestational periods of uncomplicated (gray, dotted line) and complicated pregnancies (black, continuous line). Vertical lines represent 95% CIs, and circles represent mean values. The numbers beside each circle represents the available number of pregnancies for which eGFR was measured at that particular phase of gestation. 
